Published in Immunotherapy Weekly, October 11th, 2006
The products are alleged to be in violation of the new drug and misbranding provisions of the Federal Food, Drug and Cosmetic Act.
Although these products are labeled as "dietary supplements," they are being promoted with claims typically associated with drug products. These claims are evident in the products'...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.